Karyopharm Therapeutics
Heather Levy has an extensive background in clinical operations within the pharmaceutical industry. With a strong educational foundation in Psychology, including a BA from Clark University and advanced degrees from The Graduate Center, City University of New York, Heather has also obtained a PMP Certification from the Project Management Institute. Their career has progressed from roles as Clinical Study Associate to Executive Director of Clinical Operations at various companies such as Roche Labs, Hoffmann-La Roche, and Karyopharm Therapeutics Inc. Currently, Heather holds the position of Executive Director, Clinical Operations Lead at Karyopharm Therapeutics Inc.
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).